Mameli, Giuseppe and Serra, Caterina and Astone, Vito and Castellazzi, Massimiliano and Poddighe, Luciana and Fainardi, Enrico and Neri, Walter and Granieri, Enrico and Dolei, Antonina (2008) Inhibition of multiple sclerosis–associated retrovirus as biomarker of interferon therapy. Journal of Neurovirology, Vol. 14 (1), p. 73-77. eISSN 1538-2443. Article.
Full text not available from this repository.
The authors performed a longitudinal evaluation of multiple sclerosis (MS) patients, during 1 year of therapy with interferon-β (IFN-β), by clinical examination and detection of presence in the blood and viral load of MS-associated retrovirus (MSRV), by MSRVenv-specific, fully quantitative, real time reverse transcriptase–polymerase chain reaction (RT-PCR). MSRV load in the blood was directly related to MS duration and fell below detection limits within 3 months of IFN therapy; one patient had strong progression, accompanied by total MSRV rescue. These findings suggest that evaluation of plasmatic MSRV could be considered the first prognostic marker for the individual patient, to monitor disease progression and therapy outcome.
I documenti depositati in UnissResearch sono protetti dalle leggi che regolano il diritto d'autore
Repository Staff Only: item control page